Clinical trial
Antipsychotic Discontinuation in Alzheimer's Disease
NCT00417482 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antipsychotic Discontinuation in Alzheimer's Disease
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- April 30, 2011
- Enrollment
- 180 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
aggression, agitation, alzheimer disease, psychotic disorders